 | • レポートコード：QFJ1-5637 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、気管支拡張症薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、去痰薬、その他）、用途別市場規模（病院、研究所、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・気管支拡張症薬の市場動向 ・企業の競争状況、市場シェア ・気管支拡張症薬の種類別市場規模と予測2016-2027（抗生物質、去痰薬、その他） ・気管支拡張症薬の用途別市場規模と予測2016-2027（病院、研究所、診療所、その他） ・気管支拡張症薬の北米市場規模2016-2027（アメリカ、カナダ） ・気管支拡張症薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・気管支拡張症薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・気管支拡張症薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・気管支拡張症薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Endo International Plc、GlaxoSmithKline Plc、Neopharma LLC、Pfizer Inc.、Reckitt Benckiser Group Plc） ・結論 |
Diagnosis methods of bacterial lung infections have several limitations, including failure to precisely recognize the cause of infection and inability to provide a full representation of the bacterial load present in the lungs. This has driven researchers to develop a new probe, which can detect bacteria in the lungs efficiently.
The use of this probe will also help in identifying the exact causing agent of bronchiectasis. The high-resolution computed tomography (HRCT) scan has also emerged as a popular diagnostic technique for screening bronchiectasis and other respiratory diseases. Such advances in the diagnostics of respiratory diseases will enable pulmonologists and otolaryngologists to precisely identify the stage of the disease and provide appropriate and timely treatment to patients.
Market Analysis and Insights: Global Bronchiectasis Drugs Market
The global Bronchiectasis Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Bronchiectasis Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Bronchiectasis Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Bronchiectasis Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Bronchiectasis Drugs market.
Global Bronchiectasis Drugs Scope and Market Size
Bronchiectasis Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bronchiectasis Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Antibiotics
Expectorants
Other drugs
Segment by Application
Hospital
Research institute
Clinic
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Endo International Plc
GlaxoSmithKline Plc
Neopharma LLC
Pfizer Inc.
Reckitt Benckiser Group Plc
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bronchiectasis Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Antibiotics
1.2.3 Expectorants
1.2.4 Other drugs
1.3 Market by Application
1.3.1 Global Bronchiectasis Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Research institute
1.3.4 Clinic
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Bronchiectasis Drugs Market Perspective (2016-2027)
2.2 Bronchiectasis Drugs Growth Trends by Regions
2.2.1 Bronchiectasis Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Bronchiectasis Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Bronchiectasis Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Bronchiectasis Drugs Industry Dynamic
2.3.1 Bronchiectasis Drugs Market Trends
2.3.2 Bronchiectasis Drugs Market Drivers
2.3.3 Bronchiectasis Drugs Market Challenges
2.3.4 Bronchiectasis Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bronchiectasis Drugs Players by Revenue
3.1.1 Global Top Bronchiectasis Drugs Players by Revenue (2016-2021)
3.1.2 Global Bronchiectasis Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Bronchiectasis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Bronchiectasis Drugs Revenue
3.4 Global Bronchiectasis Drugs Market Concentration Ratio
3.4.1 Global Bronchiectasis Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bronchiectasis Drugs Revenue in 2020
3.5 Bronchiectasis Drugs Key Players Head office and Area Served
3.6 Key Players Bronchiectasis Drugs Product Solution and Service
3.7 Date of Enter into Bronchiectasis Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Bronchiectasis Drugs Breakdown Data by Type
4.1 Global Bronchiectasis Drugs Historic Market Size by Type (2016-2021)
4.2 Global Bronchiectasis Drugs Forecasted Market Size by Type (2022-2027)
5 Bronchiectasis Drugs Breakdown Data by Application
5.1 Global Bronchiectasis Drugs Historic Market Size by Application (2016-2021)
5.2 Global Bronchiectasis Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Bronchiectasis Drugs Market Size (2016-2027)
6.2 North America Bronchiectasis Drugs Market Size by Type
6.2.1 North America Bronchiectasis Drugs Market Size by Type (2016-2021)
6.2.2 North America Bronchiectasis Drugs Market Size by Type (2022-2027)
6.2.3 North America Bronchiectasis Drugs Market Size by Type (2016-2027)
6.3 North America Bronchiectasis Drugs Market Size by Application
6.3.1 North America Bronchiectasis Drugs Market Size by Application (2016-2021)
6.3.2 North America Bronchiectasis Drugs Market Size by Application (2022-2027)
6.3.3 North America Bronchiectasis Drugs Market Size by Application (2016-2027)
6.4 North America Bronchiectasis Drugs Market Size by Country
6.4.1 North America Bronchiectasis Drugs Market Size by Country (2016-2021)
6.4.2 North America Bronchiectasis Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Bronchiectasis Drugs Market Size (2016-2027)
7.2 Europe Bronchiectasis Drugs Market Size by Type
7.2.1 Europe Bronchiectasis Drugs Market Size by Type (2016-2021)
7.2.2 Europe Bronchiectasis Drugs Market Size by Type (2022-2027)
7.2.3 Europe Bronchiectasis Drugs Market Size by Type (2016-2027)
7.3 Europe Bronchiectasis Drugs Market Size by Application
7.3.1 Europe Bronchiectasis Drugs Market Size by Application (2016-2021)
7.3.2 Europe Bronchiectasis Drugs Market Size by Application (2022-2027)
7.3.3 Europe Bronchiectasis Drugs Market Size by Application (2016-2027)
7.4 Europe Bronchiectasis Drugs Market Size by Country
7.4.1 Europe Bronchiectasis Drugs Market Size by Country (2016-2021)
7.4.2 Europe Bronchiectasis Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Bronchiectasis Drugs Market Size (2016-2027)
8.2 Asia-Pacific Bronchiectasis Drugs Market Size by Type
8.2.1 Asia-Pacific Bronchiectasis Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Bronchiectasis Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Bronchiectasis Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Bronchiectasis Drugs Market Size by Application
8.3.1 Asia-Pacific Bronchiectasis Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Bronchiectasis Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Bronchiectasis Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Bronchiectasis Drugs Market Size by Region
8.4.1 Asia-Pacific Bronchiectasis Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Bronchiectasis Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Bronchiectasis Drugs Market Size (2016-2027)
9.2 Latin America Bronchiectasis Drugs Market Size by Type
9.2.1 Latin America Bronchiectasis Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Bronchiectasis Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Bronchiectasis Drugs Market Size by Type (2016-2027)
9.3 Latin America Bronchiectasis Drugs Market Size by Application
9.3.1 Latin America Bronchiectasis Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Bronchiectasis Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Bronchiectasis Drugs Market Size by Application (2016-2027)
9.4 Latin America Bronchiectasis Drugs Market Size by Country
9.4.1 Latin America Bronchiectasis Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Bronchiectasis Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bronchiectasis Drugs Market Size (2016-2027)
10.2 Middle East & Africa Bronchiectasis Drugs Market Size by Type
10.2.1 Middle East & Africa Bronchiectasis Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Bronchiectasis Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Bronchiectasis Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Bronchiectasis Drugs Market Size by Application
10.3.1 Middle East & Africa Bronchiectasis Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Bronchiectasis Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Bronchiectasis Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Bronchiectasis Drugs Market Size by Country
10.4.1 Middle East & Africa Bronchiectasis Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Bronchiectasis Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Endo International Plc
11.1.1 Endo International Plc Company Details
11.1.2 Endo International Plc Business Overview
11.1.3 Endo International Plc Bronchiectasis Drugs Introduction
11.1.4 Endo International Plc Revenue in Bronchiectasis Drugs Business (2016-2021)
11.1.5 Endo International Plc Recent Development
11.2 GlaxoSmithKline Plc
11.2.1 GlaxoSmithKline Plc Company Details
11.2.2 GlaxoSmithKline Plc Business Overview
11.2.3 GlaxoSmithKline Plc Bronchiectasis Drugs Introduction
11.2.4 GlaxoSmithKline Plc Revenue in Bronchiectasis Drugs Business (2016-2021)
11.2.5 GlaxoSmithKline Plc Recent Development
11.3 Neopharma LLC
11.3.1 Neopharma LLC Company Details
11.3.2 Neopharma LLC Business Overview
11.3.3 Neopharma LLC Bronchiectasis Drugs Introduction
11.3.4 Neopharma LLC Revenue in Bronchiectasis Drugs Business (2016-2021)
11.3.5 Neopharma LLC Recent Development
11.4 Pfizer Inc.
11.4.1 Pfizer Inc. Company Details
11.4.2 Pfizer Inc. Business Overview
11.4.3 Pfizer Inc. Bronchiectasis Drugs Introduction
11.4.4 Pfizer Inc. Revenue in Bronchiectasis Drugs Business (2016-2021)
11.4.5 Pfizer Inc. Recent Development
11.5 Reckitt Benckiser Group Plc
11.5.1 Reckitt Benckiser Group Plc Company Details
11.5.2 Reckitt Benckiser Group Plc Business Overview
11.5.3 Reckitt Benckiser Group Plc Bronchiectasis Drugs Introduction
11.5.4 Reckitt Benckiser Group Plc Revenue in Bronchiectasis Drugs Business (2016-2021)
11.5.5 Reckitt Benckiser Group Plc Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Bronchiectasis Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Antibiotics
Table 3. Key Players of Expectorants
Table 4. Key Players of Other drugs
Table 5. Global Bronchiectasis Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Bronchiectasis Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Bronchiectasis Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Bronchiectasis Drugs Market Share by Regions (2016-2021)
Table 9. Global Bronchiectasis Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Bronchiectasis Drugs Market Share by Regions (2022-2027)
Table 11. Bronchiectasis Drugs Market Trends
Table 12. Bronchiectasis Drugs Market Drivers
Table 13. Bronchiectasis Drugs Market Challenges
Table 14. Bronchiectasis Drugs Market Restraints
Table 15. Global Bronchiectasis Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Bronchiectasis Drugs Market Share by Players (2016-2021)
Table 17. Global Top Bronchiectasis Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bronchiectasis Drugs as of 2020)
Table 18. Ranking of Global Top Bronchiectasis Drugs Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Bronchiectasis Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Bronchiectasis Drugs Product Solution and Service
Table 22. Date of Enter into Bronchiectasis Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Bronchiectasis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Bronchiectasis Drugs Revenue Market Share by Type (2016-2021)
Table 26. Global Bronchiectasis Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Bronchiectasis Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Bronchiectasis Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Bronchiectasis Drugs Revenue Market Share by Application (2016-2021)
Table 30. Global Bronchiectasis Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Bronchiectasis Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Bronchiectasis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Bronchiectasis Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Bronchiectasis Drugs Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Bronchiectasis Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Bronchiectasis Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Bronchiectasis Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Bronchiectasis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Bronchiectasis Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Bronchiectasis Drugs Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Bronchiectasis Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Bronchiectasis Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Bronchiectasis Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Bronchiectasis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Bronchiectasis Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Bronchiectasis Drugs Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Bronchiectasis Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Bronchiectasis Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Bronchiectasis Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Bronchiectasis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Bronchiectasis Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Bronchiectasis Drugs Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Bronchiectasis Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Bronchiectasis Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Bronchiectasis Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Bronchiectasis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Bronchiectasis Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Bronchiectasis Drugs Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Bronchiectasis Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Bronchiectasis Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Bronchiectasis Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 62. Endo International Plc Company Details
Table 63. Endo International Plc Business Overview
Table 64. Endo International Plc Bronchiectasis Drugs Product
Table 65. Endo International Plc Revenue in Bronchiectasis Drugs Business (2016-2021) & (US$ Million)
Table 66. Endo International Plc Recent Development
Table 67. GlaxoSmithKline Plc Company Details
Table 68. GlaxoSmithKline Plc Business Overview
Table 69. GlaxoSmithKline Plc Bronchiectasis Drugs Product
Table 70. GlaxoSmithKline Plc Revenue in Bronchiectasis Drugs Business (2016-2021) & (US$ Million)
Table 71. GlaxoSmithKline Plc Recent Development
Table 72. Neopharma LLC Company Details
Table 73. Neopharma LLC Business Overview
Table 74. Neopharma LLC Bronchiectasis Drugs Product
Table 75. Neopharma LLC Revenue in Bronchiectasis Drugs Business (2016-2021) & (US$ Million)
Table 76. Neopharma LLC Recent Development
Table 77. Pfizer Inc. Company Details
Table 78. Pfizer Inc. Business Overview
Table 79. Pfizer Inc. Bronchiectasis Drugs Product
Table 80. Pfizer Inc. Revenue in Bronchiectasis Drugs Business (2016-2021) & (US$ Million)
Table 81. Pfizer Inc. Recent Development
Table 82. Reckitt Benckiser Group Plc Company Details
Table 83. Reckitt Benckiser Group Plc Business Overview
Table 84. Reckitt Benckiser Group Plc Bronchiectasis Drugs Product
Table 85. Reckitt Benckiser Group Plc Revenue in Bronchiectasis Drugs Business (2016-2021) & (US$ Million)
Table 86. Reckitt Benckiser Group Plc Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bronchiectasis Drugs Market Share by Type: 2020 VS 2027
Figure 2. Antibiotics Features
Figure 3. Expectorants Features
Figure 4. Other drugs Features
Figure 5. Global Bronchiectasis Drugs Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Research institute Case Studies
Figure 8. Clinic Case Studies
Figure 9. Other Case Studies
Figure 10. Bronchiectasis Drugs Report Years Considered
Figure 11. Global Bronchiectasis Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Bronchiectasis Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Bronchiectasis Drugs Market Share by Regions: 2020 VS 2027
Figure 14. Global Bronchiectasis Drugs Market Share by Regions (2022-2027)
Figure 15. Global Bronchiectasis Drugs Market Share by Players in 2020
Figure 16. Global Top Bronchiectasis Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bronchiectasis Drugs as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Bronchiectasis Drugs Revenue in 2020
Figure 18. Global Bronchiectasis Drugs Revenue Market Share by Type (2016-2021)
Figure 19. Global Bronchiectasis Drugs Revenue Market Share by Type (2022-2027)
Figure 20. North America Bronchiectasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Bronchiectasis Drugs Market Share by Type (2016-2027)
Figure 22. North America Bronchiectasis Drugs Market Share by Application (2016-2027)
Figure 23. North America Bronchiectasis Drugs Market Share by Country (2016-2027)
Figure 24. United States Bronchiectasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Bronchiectasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Bronchiectasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Bronchiectasis Drugs Market Share by Type (2016-2027)
Figure 28. Europe Bronchiectasis Drugs Market Share by Application (2016-2027)
Figure 29. Europe Bronchiectasis Drugs Market Share by Country (2016-2027)
Figure 30. Germany Bronchiectasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Bronchiectasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Bronchiectasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Bronchiectasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Bronchiectasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Bronchiectasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Bronchiectasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Bronchiectasis Drugs Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Bronchiectasis Drugs Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Bronchiectasis Drugs Market Share by Region (2016-2027)
Figure 40. China Bronchiectasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Bronchiectasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Bronchiectasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Bronchiectasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Bronchiectasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Bronchiectasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Bronchiectasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Bronchiectasis Drugs Market Share by Type (2016-2027)
Figure 48. Latin America Bronchiectasis Drugs Market Share by Application (2016-2027)
Figure 49. Latin America Bronchiectasis Drugs Market Share by Country (2016-2027)
Figure 50. Mexico Bronchiectasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Bronchiectasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Bronchiectasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Bronchiectasis Drugs Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Bronchiectasis Drugs Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Bronchiectasis Drugs Market Share by Country (2016-2027)
Figure 56. Turkey Bronchiectasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Bronchiectasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Bronchiectasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Endo International Plc Revenue Growth Rate in Bronchiectasis Drugs Business (2016-2021)
Figure 60. GlaxoSmithKline Plc Revenue Growth Rate in Bronchiectasis Drugs Business (2016-2021)
Figure 61. Neopharma LLC Revenue Growth Rate in Bronchiectasis Drugs Business (2016-2021)
Figure 62. Pfizer Inc. Revenue Growth Rate in Bronchiectasis Drugs Business (2016-2021)
Figure 63. Reckitt Benckiser Group Plc Revenue Growth Rate in Bronchiectasis Drugs Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
気管支拡張薬のグローバル市場：規模・現状・予測2019-2025 Diagnosis methods of bacterial lung infections have several limitations, including failure to precisely recognize the cause of infection and inability to provide a full representation of the bacterial load present in the lungs. This has driven researchers to develop a new probe, which can detect bac…- 気管支拡張薬のグローバル市場：規模・現状・予測2019-2025 Diagnosis methods of bacterial lung infections have several limitations, including failure to precisely recognize the cause of infection and inability to provide a full representation of the bacterial load present in the lungs. This has driven researchers to develop a new probe, which can detect bac…
- 世界の気管支拡張症治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Bronchiectasis Therapeutic Market The global Bronchiectasis Therapeutic market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, …
- 世界の非嚢胞性線維症気管支拡張症市場規模・現状・予測（2021年-2027年） Non-cystic fibrosis bronchiectasis (NCFB) is a chronic, progressive respiratory disorder characterized by irreversibly and abnormally dilated airways, persistent cough, excessive sputum production and recurrent pulmonary infections. The changes in the bronchial walls may be due to chronic inflammati…
- 世界の起立性低血圧治療薬市場規模・現状・予測（2021年-2027年） The increasing prevalence of chronic diseases will also contribute to the growth of the OH drugs market. Orthostatic hypotension is associated with various neurodegenerative diseases, cardiovascular diseases, and diabetes. Orthostatic hypotension is difficult to treat with single-drug therapy becaus…